Risk stratification for colorectal neoplasia detection in the Flemish colorectal cancer screening programme

被引:10
|
作者
van de Veerdonk, Wessel [1 ]
Van Hal, Guido [1 ,3 ]
Peeters, Marc [2 ,5 ]
De Brabander, Isabel [4 ]
Silversmit, Geert [4 ]
Hoeck, Sarah [1 ,3 ]
机构
[1] Univ Antwerp, Fac Med & Hlth Sci, Dept Social Epidemiol & Hlth Policy, Antwerp, Belgium
[2] Antwerp Univ Hosp, Dept Oncol, Antwerp, Belgium
[3] Ctr Canc Detect, Antwerp, Belgium
[4] Belgian Canc Registry, Brussels, Belgium
[5] Univ Antwerp, MIPRO, Antwerp, Belgium
关键词
Early detection of cancer; Colorectal neoplasms; Occult blood; Risk factors; Decision making; Colonoscopy; CIGARETTE-SMOKING; FAMILY-HISTORY; ALCOHOL; HEALTH; METAANALYSIS; INDIVIDUALS;
D O I
10.1016/j.canep.2018.07.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The quantitative faecal immunochemical test (FIT) detects pre-cancerous lesions and colorectal cancer (CRC). Current CRC screening programmes are based upon a binary FIT result. This study evaluates the possibility of personalised risk prediction, based on FIT, age and gender to gain more insight into improving discrimination between normal outcomes, pre-cancerous lesions, carcinoma in situ and CRC working towards a more tailored screening approach. Methods: In this retrospective study, from October 2013 until July 2016, data from 57,421 participants who underwent a colonoscopy after a positive FIT in the Flemish CRC screening programme were analysed using a multinomial multivariable logistic regression model. Results: A significant difference in risk of detecting neoplasia was found between the established risk profiles based on the combination of the quantitative FIT, age and gender. The odds for detecting CRC in men aged 74, with a FIT result of >= 1000 ng/ml, was higher by a factor of 58.43 than that for women aged 56, with a FIT result of 75 ng/ml. Conclusion: A large difference in risk with regard to the detection of colorectal neoplasia was found, based on demographics of the population. For some participants, the chance of finding no anomalies was more than 60%. Including additional variables in a prediction model could further increase discrimination between outcomes and practicality.
引用
收藏
页码:90 / 96
页数:7
相关论文
共 50 条
  • [1] Risk Stratification for Advanced Colorectal Neoplasia According to Fecal Hemoglobin Concentration in a Colorectal Cancer Screening Program
    Auge, Josep M.
    Pellise, Maria
    Escudero, Jose M.
    Hernandez, Cristina
    Andreu, Montserrat
    Grau, Jaume
    Buron, Andrea
    Lopez-Ceron, Maria
    Bessa, Xavier
    Serradesanferm, Anna
    Piraces, Merce
    Macia, Francesc
    Guayta, Rafael
    Filella, Xavier
    Molina, Rafael
    Jimenez, Wladimiro
    Castells, Antoni
    [J]. GASTROENTEROLOGY, 2014, 147 (03) : 628 - +
  • [2] The Your Disease Risk Index for Colorectal Cancer Is an Inaccurate Risk Stratification Tool for Advanced Colorectal Neoplasia at Screening Colonoscopy
    Schroy, Paul C., III
    Coe, Alison M.
    Mylvaganam, Shamini R.
    Ahn, Lynne B.
    Lydotes, Maria A.
    Robinson, Patricia A.
    Davis, Julie T.
    Chen, Clara A.
    Ashba, Jacqueline
    Atkinson, Michael L.
    Colditz, Graham A.
    Heeren, Timothy C.
    [J]. CANCER PREVENTION RESEARCH, 2012, 5 (08) : 1044 - 1052
  • [3] Risk Stratification Score Improves Sensitivity for Advanced Colorectal Neoplasia in Colorectal Cancer Screening: The Oshima Study Workgroup
    Sekiguchi, Masau
    Kakugawa, Yasuo
    Ikematsu, Hiroaki
    Hotta, Kinichi
    Konda, Kenichi
    Tanaka, Yusaku
    Takamaru, Hiroyuki
    Yamada, Masayoshi
    Sakamoto, Taku
    Saito, Yutaka
    Imai, Kenichiro
    Ito, Sayo
    Koga, Yoshikatsu
    Iwasaki, Motoki
    Murakami, Yoshitaka
    Matsuda, Takahisa
    [J]. CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (03) : e00319
  • [4] Risk stratification for colorectal cancer and implications for screening
    Tejpar, S
    [J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 2005, 68 (02): : 241 - 242
  • [5] Biophotonic risk stratification for colorectal cancer screening
    Roy, Hemant K.
    Backman, Vadim
    Lynch, Henry T.
    [J]. CANCER BIOMARKERS, 2008, 4 (03) : 127 - 128
  • [6] Risk Stratification for Advanced Colorectal Neoplasia
    Berstad, Paula
    Loberg, Magnus
    Kalager, Mette
    Jorgensen, Anita
    Garborg, Kjetil
    Ruud, Hans Kristian
    Bretthauer, Michael
    Hoff, Geir
    [J]. CANCER PREVENTION RESEARCH, 2012, 5 (12) : 1405 - 1405
  • [7] Does the Flemish colorectal cancer screening programme reach equity in FIT uptake?
    Hoeck, S.
    van de Veerdonk, W.
    De Brabander, I
    Kellen, E.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2019, 29 (06): : 1108 - 1114
  • [8] Predictors of Advanced Colorectal Neoplasia for Colorectal Cancer Screening
    Wong, Martin C. S.
    Lam, Thomas Y. T.
    Tsoi, Kelvin K. F.
    Chan, Victor C. W.
    Hirai, Hoyee W.
    Ching, Jessica Y. L.
    Sung, Joseph J. Y.
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2014, 46 (05) : 433 - 439
  • [9] Early Detection of and Screening for Colorectal Neoplasia
    Bresalier, Robert S.
    [J]. GUT AND LIVER, 2009, 3 (02) : 69 - 80
  • [10] The impact of aspirin, statins and ACE-inhibitors on the presentation of colorectal neoplasia in a colorectal cancer screening programme
    D Mansouri
    D C McMillan
    C S D Roxburgh
    E M Crighton
    P G Horgan
    [J]. British Journal of Cancer, 2013, 109 : 249 - 256